The National Company Law Tribunal (NCLT) on Monday approved Gurgaon-based Dhanuka Laboratories’ Rs 1,116 crore resolution plan to take over the debt ridden Orchid PharmaNSE 4.17 % in what could be termed as yet another...
Bristol-Myers plans to divest Celgene’s psoriasis drug
Bristol-Myers Squibb Co on Monday offered to divest Celgene Corp’s psoriasis treatment Otezla to allay concerns raised by the U.S. competition regulator, and pushed back the closing of their $74 billion deal. The...
Advent International emerges sole bidder for Bharat Serums
Private equity group Advent International has emerged as the sole contender for acquiring Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) with a bid worth Rs 3,600 crore ($520 million) after rival...
GSK kicks off sale of $1.2 billion consumer health drugs: sources
GlaxoSmithKline (GSK) has kicked off the sale of some consumer health brands as it seeks to raise about 1 billion pounds ($1.26 billion) before pressing ahead with a spinoff of its consumer healthcare business, sources...
Ready to revise resolution plan for Orchid Pharma: Accord to NCLT
Even as the resolution plan of Dhanuka Laboratories for the Orchid Pharma insolvency process is with the National Company Law Tribunal (NCLT), Chennai-based Accord Life Spec Pvt Ltd has told the tribunal that it is...
Pfizer acquires Array Biopharma, valued at $11.4 billion
US pharmaceutical giant Pfizer on Monday announced the acquisition of Array BioPharma, a biotechnology firm that specializes in cancer drugs, the latest in a long list of biotech mergers in recent years. In a statement...
UniQure NV weighs options including sale: Bloomberg
Gene therapy company UniQure NV is exploring options including a sale amid interest from other pharmaceutical companies looking to expand in gene therapy, Bloomberg reported on Sunday citing people with knowledge of the...
Roche’s $4.3 billion Spark bid delayed again amid U.S., UK scrutiny
Swiss drugmaker Roche’s $4.3 billion takeover of U.S. gene therapy specialist Spark Therapeutics has been pushed back again, possibly beyond the first half, as regulators continue to scrutinize the deal for its effect...
Three pharma firms in second race for Orchid Pharma resolution process
There are three pharmaceutical bidders for debt-ridden Orchid Pharma Ltd in the second round of Corporate Insolvency Resolution Process (CIRP) — Gurgaon-based Dhanuka Laboratories, Chennai-based Accord Life Spec...
Dhanuka Laboratories leads race for Orchid Pharma
Gurgaon-based Dhanuka Laboratories has been shortlisted as the highest qualified bidder to take over distressed company Orchid Pharma NSE 4.12 %. The company has bid less than 1,000 crore for Orchid that owes lenders...
JB Chemicals promoters to offload 57% stake
The promoters of Mumbai-based JB Chemicals have put their business up for sale, mandating investment bank Avendus to look for a buyer for their 57% stake in the company, said four people with direct knowledge of the...
CCI approves GSK, Pfizer consumer healthcare JV formation
The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer. GSK, in December 2018, had said it...
